A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinoma

Indu Khatri, Manoj K. Bhasin
doi: https://doi.org/10.1101/2020.04.16.20061515

Article Information

doi 
https://doi.org/10.1101/2020.04.16.20061515
History 
  • April 22, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Indu Khatri1,3 and
  2. Manoj K. Bhasin1,2,*
  1. 1Division of IMBIO, Department of Medicine, Beth Israel Lahey Health, Harvard Medical School, Boston MA 02215
  2. 2Department of Pediatrics and Biomedical Informatics, Children Healthcare of Atlanta, Emory School of Medicine, Atlanta, GA 30322
  3. 3Division of Immunohematology and Blood transfusion, Leiden University Medical Center, Leiden, The Netherlands, 2333ZA
  1. ↵*Corresponding Author
    Manoj K. Bhasin, PhD, E-mail: manoj.bhasin{at}emory.edu
Back to top
Posted April 22, 2020.
Download PDF
Data/Code
Email
A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinoma
Indu Khatri, Manoj K. Bhasin
medRxiv 2020.04.16.20061515; doi: https://doi.org/10.1101/2020.04.16.20061515
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area